Faculty Research

dosimetrits looking at a scan

As the state's only academic health center, OHSU's breakthrough research leads to new cures, new standards of care, and a better understanding of the basic science that drives biomedical discovery. OHSU researchers are exploring new basic, clinical, and applied research frontiers. Read about research at OHSU

Interested in Cancer Clinical Trials? OHSU Knight Cancer Institute takes part in hundreds of clinical trials, learn more about participating in a clinical trial.

     Anand Lab

     Fuller Lab

     Nolz Lab

The talents and resources of hundreds of individuals, institutions, and industries must be combined to achieve successful diagnosis and treatment of cancer and other diseases.

To help ensure success in the diagnosis and treatment of cancers and diseases, we have developed ongoing relationships with the following institutions:

This collaboration between institutions allows our team to be amongst the first to access any newly researched technologies.

This gives our team a unique opportunity to devise applications for improving the diagnosing of cancers and developing innovative therapeutic treatments. So when you enter our facilities, you can rest assured that the very best minds and machines are devoted to your care.

In the news: Radiation Medicine

September 10, 2019

Aaron Grossberg, M.D., Ph.D. and Josh Walker, M.D., Ph.D. on have been named 2019 Lamfrom Laureates. The Knight Cancer Institute established the Hildegard Lamfrom Research Scholar Awards to support promising early-stage cancer researchers at OHSU as they reach critical career transitions. The awards provide up to $100,000 over a two-year period.

September 18, 2019

The faculty and residents of the Department of Radiation Medicine presented at the 2019 ASTRO Annual Meeting. See a list of those presentation here: Radiation Medicine Presentations

August 14, 2019

Timur Mitin, M.D., Ph.D. was interviewed by the Slavic Family Media Center about OHSU's oncology program. Watch the interview here.